RFG Advisory LLC Sells 7,311 Shares of Danaher Corporation $DHR

RFG Advisory LLC lessened its position in shares of Danaher Corporation (NYSE:DHRFree Report) by 54.8% during the third quarter, Holdings Channel reports. The institutional investor owned 6,027 shares of the conglomerate’s stock after selling 7,311 shares during the quarter. RFG Advisory LLC’s holdings in Danaher were worth $1,195,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently added to or reduced their stakes in DHR. White Pine Capital LLC lifted its holdings in Danaher by 1.4% during the second quarter. White Pine Capital LLC now owns 3,494 shares of the conglomerate’s stock valued at $690,000 after purchasing an additional 49 shares during the last quarter. SOL Capital Management CO raised its position in shares of Danaher by 2.8% in the third quarter. SOL Capital Management CO now owns 1,829 shares of the conglomerate’s stock valued at $363,000 after purchasing an additional 50 shares during the period. Purkiss Capital Advisors LLC lifted its stake in shares of Danaher by 3.9% during the 3rd quarter. Purkiss Capital Advisors LLC now owns 1,327 shares of the conglomerate’s stock valued at $263,000 after buying an additional 50 shares in the last quarter. Boyd Watterson Asset Management LLC OH lifted its stake in shares of Danaher by 2.1% during the 2nd quarter. Boyd Watterson Asset Management LLC OH now owns 2,524 shares of the conglomerate’s stock valued at $499,000 after buying an additional 51 shares in the last quarter. Finally, Howard Capital Management Group LLC boosted its holdings in Danaher by 4.8% in the 3rd quarter. Howard Capital Management Group LLC now owns 1,159 shares of the conglomerate’s stock worth $230,000 after buying an additional 53 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Activity

In related news, Director Teri List sold 3,298 shares of the stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total transaction of $746,997.00. Following the transaction, the director owned 20,762 shares of the company’s stock, valued at approximately $4,702,593. This trade represents a 13.71% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 11.10% of the company’s stock.

Wall Street Analyst Weigh In

DHR has been the topic of several recent research reports. Barclays increased their target price on Danaher from $225.00 to $250.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 22nd. Robert W. Baird set a $251.00 price objective on Danaher in a research note on Thursday, January 29th. Guggenheim raised their target price on Danaher from $250.00 to $275.00 and gave the stock a “buy” rating in a research note on Friday, January 2nd. The Goldman Sachs Group decreased their price target on Danaher from $270.00 to $265.00 and set a “buy” rating on the stock in a research report on Thursday, January 29th. Finally, Morgan Stanley began coverage on shares of Danaher in a research report on Monday, December 1st. They issued an “overweight” rating and a $270.00 price objective for the company. Twenty investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $253.86.

Read Our Latest Report on DHR

Danaher Stock Performance

Danaher stock opened at $219.97 on Thursday. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $242.80. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87. The stock has a market cap of $155.38 billion, a P/E ratio of 43.65, a price-to-earnings-growth ratio of 2.97 and a beta of 0.91. The firm’s fifty day moving average price is $229.15 and its 200-day moving average price is $215.40.

Danaher (NYSE:DHRGet Free Report) last released its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 EPS for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The business had revenue of $6.84 billion for the quarter, compared to analysts’ expectations of $6.79 billion. During the same quarter in the prior year, the firm earned $2.14 earnings per share. The firm’s revenue was up 4.6% on a year-over-year basis. On average, equities research analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 30th. Stockholders of record on Friday, December 26th were issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date was Friday, December 26th. Danaher’s payout ratio is presently 25.40%.

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.